| Line item | 2025-12-31 FY | 2025-09-30 FY | 2025-06-30 FY | 2025-03-31 FY | 2024-12-31 FY | 2024-09-30 FY | 2024-06-30 FY | 2024-03-31 FY |
|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – | – |
| Operating Expenses | $147.87M | – | – | – | $156.47M | – | – | – |
| R&D | – | – | – | – | – | – | – | – |
| SG&A | $6.33M | – | – | – | $7.16M | – | – | – |
| Operating Income | – | – | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – | – | – |
| Net Income | -$20.63M | $35.88M | $27.32M | -$42.70M | $33.90M | -$379.00K | $22.38M | $6.45M |
| EPS (basic) | – | – | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – | – | – |
| Shares (diluted) | $52.34M | $52.07M | $52.63M | $53.07M | $53.56M | $53.44M | $53.60M | $53.96M |